Tom Klein Robbenhaar
Director/Board Member at Synexa Life Sciences BV
Network origin in Tom Klein Robbenhaar first degree
Entity | Entity type | Industry | |
---|---|---|---|
Gilde Healthcare Partners BV
Gilde Healthcare Partners BV Investment ManagersFinance Gilde Healthcare Partners BV is a Private Equity/Venture Capital firm, a subsidiary of Gilde Healthcare Holding BV founded in 1999 by Pieter van der Meer and Edwin William de Graaf. Gilde Healthcare Partners BV is headquartered in Utrecht with additional office in Cambridge.
21
| Subsidiary | Investment Managers | 21 |
Synexa Life Sciences BV
Synexa Life Sciences BV BiotechnologyHealth Technology Synexa Life Sciences BV is a Dutch company that specializes in Biomarker and Bioanalysis Research Services. The company is based in Leiden, Netherlands. The company has expertise in designing and delivering biomarker strategies for biopharma clients. and has subsidiaries in Finland. The company was founded in 2003 by Justin Devine, Patrick Bouic, Paul O'Riordan. The CEO is Emile Lens.
6
| Holding Company | Biotechnology | 6 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Tom Klein Robbenhaar via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Erasmus University Rotterdam | College/University | Graduate Degree Graduate Degree | |
Gilde Investment Management BV
Gilde Investment Management BV Investment ManagersFinance Gilde Investment Management BV is an Independent Private Equity firm founded in 1982. Gilde Investment Management BV is headquartered in Utrecht. | Investment Managers | Investment Committee Member Private Equity Investor | |
University of Leiden | College/University | Graduate Degree Undergraduate Degree | |
Gilde Healthcare Holding BV
Gilde Healthcare Holding BV Financial ConglomeratesFinance Gilde Healthcare Holding BV is an investment holding Dutch company. The private company is based in Utrecht, NL. and has subsidiaries in Australia, Netherlands, United States and Germany. The CEOs of the company are Edwin William de Graaf, Marc Olivier Perret. | Financial Conglomerates | Chief Executive Officer Chief Executive Officer | |
University of Cambridge | College/University | Doctorate Degree Doctorate Degree | |
CropDesign NV
CropDesign NV Miscellaneous Commercial ServicesCommercial Services CropDesign NV develops traits for cereal crops. It delivers agronomic traits for the global commercial seed markets. The firm focuses on enhancing grain yield in crops such as corn and rice, and increasing biomass of energy crops. Its platform, TraitMill, lows evaluating the effect of genes on the performance of plants under different growing conditions, including drought and low nutrient stress. The company was founded in 1998 and is headquartered in Zwijnaarde, Blgium. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
INSEAD | College/University | Masters Business Admin Masters Business Admin | |
Ice Lake Capital Management BV
Ice Lake Capital Management BV Investment ManagersFinance Ice Lake Capital Management BV (IceLake Capital) is a private equity firm founded in 2018 by Bastiaan Hagenouw, Matteo Racca and Vincent Lüning. The firm is headquartered in Amsterdam, the Netherlands. | Investment Managers | Founder | |
Lumeon Ltd.
Lumeon Ltd. Packaged SoftwareTechnology Services Lumeon Ltd. operates as a digital health company. It offers cloud-based management platform for outpatient care providers including doctors, ophthalmologists, and physiotherapists. The firm?s platform offers pre-operative and discharge readiness, chronic disease, post-acute care, lifestyle coaching, and imaging optimization solutions. The company was founded by Robbie M. Hughes on August 4, 2005 and is headquartered in London, the United Kingdom. | Packaged Software | Director/Board Member | |
Definiens AG
Definiens AG Packaged SoftwareTechnology Services Definiens AG is a holding company, which engages in the development and market of biomedical imaging and data analysis software solutions. The firm specializes in the design and manufacture of imaging software suites for drug discovery, development, and diagnostics applications. It engages in the custom image analysis projects for the biopharmaceutical industry, spanning drug discovery, translational research, and clinical research. It offers image analysis processing, integration and deployment, planning, and consulting services. The company was founded by Gerd Binnig in 1994 and is headquartered in Munich, Germany. | Packaged Software | Director/Board Member | |
University of Bocconi | College/University | Undergraduate Degree | |
Symeres BV
Symeres BV Pharmaceuticals: OtherHealth Technology Symeres provides molecule contract research, discovery, development and manufacturing services. The firm offers discovery chemistry, medicinal chemistry, early process research and GMP production services. The company is headquartered in Groningen, the Netherlands. | Pharmaceuticals: Other | Director/Board Member | |
Alivio Therapeutics, Inc.
Alivio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alivio Therapeutics, Inc. develops therapies to treat inflammatory disorders through targeted disease immunomodulation. The company was founded by Robert S. Langer, Jeffrey Karp, John LaMattima, Brian Leuthner, Bennett Shapiro, Eric Elenko, Joep Muijrers, and Stephen Muniz and is headquartered in Boston, MA. | Pharmaceuticals: Major | Founder | |
Parcom Capital Management BV
Parcom Capital Management BV Investment ManagersFinance Parcom Capital Management BV is an independent private equity firm founded in 1982. Parcom Capital Management BV is headquartered in Amsterdam. | Investment Managers | Private Equity Analyst | |
McKinsey & Co., Inc. (Belgium)
McKinsey & Co., Inc. (Belgium) Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consultancy services. It serves businesses, governments, non governmental organizations, and non-profit organizations. The company was founded by James O. McKinsey in 1926 and is headquartered in Brussels, Belgium. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
KARA THER | Pharmaceuticals: Major | Director/Board Member | |
Radboud University Nijmegen | College/University | Graduate Degree | |
BNP Paribas Fortis (New York Branch)
BNP Paribas Fortis (New York Branch) Regional BanksFinance Part of TEB Holding AS, BNP Paribas Fortis (New York Branch) is a commercial bank. The company is based in New York, NY. | Regional Banks | Corporate Officer/Principal | |
Puretech Health LLC
Puretech Health LLC Investment ManagersFinance Puretech Health LLC (PureTech Ventures) is a venture capital subsidiary of PureTech Health Plc founded in 2000 by Daphne Zohar, Robert Langer and Ben Shapiro. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Director of Finance/CFO | |
NYXOAH SA | Medical Specialties | Director/Board Member | |
BG MEDICINE, INC. | Medical Specialties | Director/Board Member | |
Draupnir Bio ApS
Draupnir Bio ApS Pharmaceuticals: MajorHealth Technology Draupnir Bio ApS engages in the manufacture and distribution of biotechnological and pharmaceutical products. It also provides medical research services. The company was founded on April 4, 2017 and is headquartered in Risskov, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
EQT Netherlands Management BV
EQT Netherlands Management BV Investment ManagersFinance EQT Partners BV operates as a financial holding company with interests in providing investments. The company was founded on July 3, 2012 and is headquartered in Schiphol, the Netherlands. | Investment Managers | Private Equity Analyst | |
Oxford Science Enterprises PLC
Oxford Science Enterprises PLC Investment ManagersFinance Oxford Science Enterprises PLC (Oxford Science Enterprises) is a venture capital firm founded in 2015. The firm is headquartered in Oxford, United Kingdom. | Investment Managers | Private Equity Investor | |
ADCendo ApS
ADCendo ApS BiotechnologyHealth Technology ADCendo ApS is a Danish company that is focused on developing antibody-drug conjugates (ADCs) to treat underserved cancers. The company is based in Humlebaek, Denmark. The company completed a series A extension financing round in 2023, which brought its funds to 82 million EUR to advance into clinical development. The investors in the company include Novo Holdings, Ysios Capital, Pontifax Venture Capital, RA Capital Management, HealthCap, and Gilde Healthcare. The company was founded in 2017 by Christoffer Nielsen, Henrik Stage. Michael Pehl has been the CEO of the company since 2021. | Biotechnology | Director/Board Member | |
Anterra Capital BV
Anterra Capital BV Investment ManagersFinance Anterra Capital BV (Anterra Capital) is an independent private equity firm founded in 2013. The firm is headquartered in Amsterdam, Netherlands. | Investment Managers | Private Equity Analyst | |
Veris Investments BV
Veris Investments BV Investment ManagersFinance Veris Investments BV is an independent investment company founded in 2013 having headquartered at Amsterdam, The Netherlands. | Investment Managers | Private Equity Investor | |
Rabo Private Equity
Rabo Private Equity Investment ManagersFinance Rabo Private Equity (RPE) is the private equity arm of the Rabobank Group and is headquartered in Utrecht. RPE originated in 1972 following the merger of two separate Dutch cooperative banks, the Cooperatieve Centrale Raiffeisen-Boerenleenbank in Utrecht and the Cooperatieve Centrale Boerenleenbank in Eindhoven. The firm was formally established in 1998. RPE is based in Utrecht and operates through two separate entities, Rabo Participaties and Rabo Capital. | Investment Managers | Private Equity Investor | |
Amphista Therapeutics Ltd.
Amphista Therapeutics Ltd. BiotechnologyHealth Technology Amphista Therapeutics Ltd. is a biopharmaceutical company based in Biocity Glasgow, UK. The British company is focused on creating first-in-class therapeutics that selectively and efficiently degrade and remove disease-causing proteins using targeted protein degradation (TPD). The company's pipeline of novel small molecules is focused on challenging diseases, including cancer. Amphista is a spin-out of Professor Alessio Ciulli's labs at the University of Dundee and is funded by leading life science investors, including Advent Life Sciences, the European Investment Fund, the Scottish Investment Bank, and Biomotiv. The CEO of the company is Nicola Thompson. | Biotechnology | Director/Board Member | |
Swiss Federal Institute of Technology | College/University | Graduate Degree | |
University of California, Berkeley | College/University | Graduate Degree | |
LAVA THERAPEUTICS N.V. | Biotechnology | Director/Board Member | |
Lumeon, Inc. | Director/Board Member | ||
Sapiens Steering Brain Stimulation BV
Sapiens Steering Brain Stimulation BV Electronic Equipment/InstrumentsElectronic Technology Sapiens Steering Brain Stimulation BV develops medical devices. The company was founded by Sjaak Deckers in 2011 and is headquartered in Eindhoven, the Netherlands. | Electronic Equipment/Instruments | Director/Board Member | |
Blue Hat Holding BV
Blue Hat Holding BV Miscellaneous Commercial ServicesCommercial Services Blue Hat Holding BV provides management services. The private company is based in Eindhoven, Netherlands. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Big Health Ltd.
Big Health Ltd. Information Technology ServicesTechnology Services Big Health Ltd. provides digital sleep improvement program to overcome sleep related disorders. It develops and provides web and mobile applications that offers cognitive behavioral therapy for insomniacs. The company was founded by Colin Espie and Peter Hames in 2010 and is headquartered in London, the United Kingdom. | Information Technology Services | Director/Board Member | |
Foundry Innovation & Research 1 Ltd.
Foundry Innovation & Research 1 Ltd. Medical SpecialtiesHealth Technology Foundry Innovation & Research 1 Ltd. develops novel therapeutic devices. It has evolved into one of the leading clusters for medical devices globally. The company was headquartered in Dublin, Ireland. | Medical Specialties | Director/Board Member | |
LSP Advisory BV
LSP Advisory BV Investment ManagersFinance Part of LSP Advisory Group BV, EQT Life Sciences is a healthcare investment firm based in Amsterdam, Netherlands. EQT Life Sciences has been connecting investors to inventors in the healthcare sector for over 30 years. The Dutch company has invested in close to two hundred private companies, raising billions of additional capital directed at supporting their R & D. EQT Life Sciences believes in fostering life and constant innovation in healthcare to achieve that goal. The company was founded in 1998, and Mark A. Wegter has been the CEO since then. Recently, EQT Life Sciences was acquired by EQT AB, one of the largest private equity firms in Europe, and among the top-ten private equity firms globally. | Investment Managers | Director/Board Member | |
PURETECH HEALTH PLC | Biotechnology | Director of Finance/CFO | |
LSP Management Group BV
LSP Management Group BV Investment ManagersFinance LSP Management Group BV (LSP) is an independent European venture capital firm which was founded by Martijn Kleijwegt, Frits van der Have and Tom Schwarz in 1998. Headquartered in Amsterdam, the firm provides financing to early- to mid-stage life science companies. | Investment Managers | Investment Committee Member | |
Coöperatieve Gilde Healthcare II UA | Investment Managers | Corporate Officer/Principal | |
Ecole Centrale Lyon | College/University | Undergraduate Degree | |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Pharmaceuticals: Major | Corporate Officer/Principal | |
INNATE PHARMA | Pharmaceuticals: Major | Director/Board Member |
Statistics
International
Netherlands | 21 |
United States | 12 |
United Kingdom | 6 |
France | 5 |
Belgium | 4 |
Sectoral
Finance | 17 |
Health Technology | 16 |
Consumer Services | 10 |
Commercial Services | 5 |
Technology Services | 4 |
Operational
Director/Board Member | 49 |
Private Equity Investor | 23 |
Private Equity Analyst | 12 |
Founder | 8 |
Corporate Officer/Principal | 7 |
Most connected contacts
Insiders | |
---|---|
Edwin de Graaf | 14 |
Janke Dittmer | 13 |
Pieter van der Meer | 12 |
Arthur Franken | 11 |
Marc Olivier Perret | 10 |
Joep Muijrers | 10 |
Matteo Racca | 7 |
Stefan Luzi | 6 |
Duncan Baird | 4 |
Sanne de Jongh | 4 |
Daan Meijners | 3 |
Boyd Rutten | 2 |
Redmar Koene | 2 |
Stephan Wachtveitl | 2 |
Jasper van Gorp | 2 |
- Stock Market
- Insiders
- Tom Klein Robbenhaar
- Company connections